Shareholders Foundation, Inc.

NYSE:BIO Investor Alert: Investigation over Possible Securities Laws Violations by Bio-Rad Laboratories, Inc.

An investigation for investors in NYSE:BIO shares over potential securities laws violations by Bio-Rad Laboratories was announced and NYSE:BIO stockholders should contact the Shareholders Foundation.

 

San Diego, CA -- (SBWIRE) -- 01/23/2017 -- An investigation was announced for investors of Bio-Rad Laboratories, Inc. (NYSE:BIO) shares over potential securities laws violations by Bio-Rad Laboratories, Inc. in connection certain financial statements.

Investors who purchased shares of Bio-Rad Laboratories, Inc. (NYSE:BIO), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm focuses on whether a series of statements by Bio-Rad Laboratories, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On May 4, 2010, Bio-Rad Laboratories, Inc disclosed that it had self-reported to the U.S. Securities and Exchange Commission ("SEC") and the U.S. Department of Justice ("DOJ") after an internal review identified certain practices that violated the Foreign Corrupt Practices Act of 1977.

On November 3, 2014, Bio-Rad Laboratories, Inc agreed to pay $55 million to settle allegations by U.S. authorities that the Company's subsidiaries had paid bribes to foreign officials in Russia, Thailand and Vietnam and falsified records to mask these bribes as legitimate expenses.

On May 27, 2015, Bio-Rad Laboratories' former General Counsel Sanford Wadler filed a lawsuit alleging that he was fired in 2013 after raising concerns to the Company's audit committee about bribery practices in China and for refusing to turn a blind eye to corruption. Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) grew from $90.19 per share in September 2011 to as high as $194.20 per share on January 10, 2017.

On January 20, 2017, NYSE:BIO shares closed at $186.91 per share.

Those who purchased shares of Bio-Rad Laboratories, Inc. have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com